Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1999, p. 4086-4092, Vol. 37, No. 12
Maladies Infectieuses et Immunologie,
Received 1 March 1999/Returned for modification 3 May 1999/Accepted 16 August 1999
An immunoglobulin G immunoblot was developed with antigenic
extracts of Borrelia burgdorferi sensu stricto,
B. garinii, B. afzelii, and B. valaisiana genospecies and was reacted with sera from patients
with neuroborreliosis, acrodermatitis, and Lyme arthritis. A detailed
analysis of the reactivities of the protein bands was performed, and a
two-step scoring procedure was selected to determine the preferential
reactivity of sera to one particular genospecies. The discriminative
potential of 5 proteins (12-kDa, 16-kDa, 18-kDa, OspA, and 66-kDa
proteins) was used as a rapid first-step scoring method, followed by
scoring of 14 additional protein bands if necessary. The advantage of
this procedure is the low percentage of serum samples with inconclusive
results for one of the four species (10% for patients with
neuroborreliosis, 6% for patients with acrodermatitis chronica
atrophicans, and 6% for patients with Lyme arthritis). Among 31 serum
samples from patients with neuroborreliosis, 16 were more reactive to
B. garinii, 7 were more reactive to B. afzelii,
3 were more reactive to B. valaisiana, and 2 were more
reactive to B. burgdorferi sensu stricto. Of 31 serum
samples from patients with acrodermatitis, 26 showed a higher level of
reactivity to B. afzelii. Of 34 serum samples from patients
with Lyme arthritis, 21 were more reactive to B. burgdorferi sensu stricto, 10 were more reactive to B. afzelii, and 1 was more reactive to B. valaisiana.
Our results suggest an organotropism of Borrelia species
and provide some evidence of a pathogenic potential of B. valaisiana in humans.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Scored Antibody Reactivity Determined by
Immunoblotting Shows an Association between Clinical Manifestations and
Presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. Valaisiana
in Humans
*
Corresponding author. Mailing address: Maladies
Infectieuses et Immunologie, Institut Central des Hôpitaux
Valaisans, Av. Grand-Champsec, CH-1950 Sion, Switzerland. Phone: 41 27 603 47 90. Fax: 41 27 603 48 93. E-mail:
olivier.peter{at}ichv.vsnet.ch.
Journal of Clinical Microbiology, December 1999, p. 4086-4092, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|